Masashi Suganuma

1.4k total citations
22 papers, 1.2k citations indexed

About

Masashi Suganuma is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Masashi Suganuma has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Surgery. Recurrent topics in Masashi Suganuma's work include Tea Polyphenols and Effects (3 papers), Cancer-related Molecular Pathways (3 papers) and Metastasis and carcinoma case studies (2 papers). Masashi Suganuma is often cited by papers focused on Tea Polyphenols and Effects (3 papers), Cancer-related Molecular Pathways (3 papers) and Metastasis and carcinoma case studies (2 papers). Masashi Suganuma collaborates with scholars based in Japan and United States. Masashi Suganuma's co-authors include Hirota Fujiki, Naoko Sueoka, Sachiko Okabe, Yasuko Kai, Eisaburo Sueoka, Takumi Kawabe, Takahiko Funabiki, Takashi Okamoto, Tomohiko Yamane and Toshio Takahashi and has published in prestigious journals such as Blood, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Masashi Suganuma

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Suganuma Japan 14 504 349 266 192 129 22 1.2k
Valeria Naponelli Italy 20 207 0.4× 529 1.5× 116 0.4× 104 0.5× 76 0.6× 35 1.2k
Weimin Guo United States 20 173 0.3× 657 1.9× 232 0.9× 105 0.5× 68 0.5× 49 1.5k
Yukiko Miura Japan 10 295 0.6× 914 2.6× 271 1.0× 74 0.4× 122 0.9× 21 1.6k
Taiki Mori Japan 16 264 0.5× 407 1.2× 194 0.7× 46 0.2× 35 0.3× 29 877
Sheng Zhang China 21 280 0.6× 451 1.3× 145 0.5× 38 0.2× 79 0.6× 67 1.0k
Juan Mestre United States 19 139 0.3× 625 1.8× 107 0.4× 359 1.9× 191 1.5× 27 2.0k
Ajay Rana India 20 203 0.4× 499 1.4× 262 1.0× 98 0.5× 62 0.5× 39 1.2k
Min‐Ho Suh South Korea 20 164 0.3× 621 1.8× 99 0.4× 156 0.8× 44 0.3× 40 1.3k
Yuki Kawakami Japan 22 126 0.3× 396 1.1× 269 1.0× 51 0.3× 113 0.9× 47 1.2k
Mun-Ock Kim South Korea 23 70 0.1× 956 2.7× 131 0.5× 151 0.8× 113 0.9× 59 1.7k

Countries citing papers authored by Masashi Suganuma

Since Specialization
Citations

This map shows the geographic impact of Masashi Suganuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Suganuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Suganuma more than expected).

Fields of papers citing papers by Masashi Suganuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Suganuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Suganuma. The network helps show where Masashi Suganuma may publish in the future.

Co-authorship network of co-authors of Masashi Suganuma

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Suganuma. A scholar is included among the top collaborators of Masashi Suganuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Suganuma. Masashi Suganuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Tianyu, et al.. (2025). Allogenic Mitochondria and Associated Organelle Complex Treatment Attenuates High-Fat Diet-Induced Adipose Tissue Remodeling. Circulation Reports. 7(8). 661–669. 1 indexed citations
3.
Field, Rachael L., Rocky Giwa, Wentong Jia, et al.. (2024). Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome. Nature Metabolism. 6(10). 1886–1896. 22 indexed citations
4.
Hashimoto, Daigo, Hajime Senjo, Zixuan Zhang, et al.. (2022). Intercellular Mitochondrial Transfer Enhances Metabolic Fitness and Anti-Tumor Effects of CAR T Cells. Blood. 140(Supplement 1). 2356–2357. 8 indexed citations
5.
Suganuma, Masashi, et al.. (2007). Migration behaviour and pathogenesis of five ascarid nematode species in the Mongolian gerbilMeriones unguiculatus. Journal of Helminthology. 81(1). 43–47. 20 indexed citations
6.
Arai, Masayoshi, Hitoshi Sato, Hidetaka Kobayashi, et al.. (2004). Selective inhibition of bleomycin-induced G2 cell cycle checkpoint by simaomicin α. Biochemical and Biophysical Research Communications. 317(3). 817–822. 17 indexed citations
7.
Arai, Masayoshi, Yukio Koizumi, Hitoshi Sato, et al.. (2004). Boromycin Abrogates Bleomycin-induced G2 Checkpoint. The Journal of Antibiotics. 57(10). 662–668. 14 indexed citations
8.
Kawabe, Takumi, et al.. (2002). Cdc25C interacts with PCNA at G2/M transition. Oncogene. 21(11). 1717–1726. 52 indexed citations
9.
Suganuma, Masashi, Miki Kurusu, Sachiko Okabe, et al.. (2001). Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.. PubMed. 61(17). 6356–9. 58 indexed citations
10.
Sakurai, Yoichi, Mitsutaka Shoji, Toshiki Matsubara, et al.. (2001). Spontaneous necrosis of gallbladder carcinoma in patient with pancreaticobiliary maljunction. Journal of Hepato-Biliary-Pancreatic Surgery. 8(1). 95–100. 2 indexed citations
11.
Suganuma, Masashi, Naoko Takahashi, Toshifumi Tetsuka, et al.. (2000). Evidence that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-κB. Oncogene. 19(18). 2233–2239. 32 indexed citations
12.
Ochiai, Masahiro, Toshiki Matsubara, Takahiko Funabiki, et al.. (2000). Gastritis cystica polyposa associated with a gastric stump carcinoma, with special reference to cell kinetics and p53 gene aberrations. Gastric Cancer. 3(3). 165–170. 15 indexed citations
13.
Suganuma, Masashi, Sachiko Okabe, Yasuko Kai, et al.. (1999). Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.. PubMed. 59(1). 44–7. 202 indexed citations
14.
Suganuma, Masashi, et al.. (1999). Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation.. PubMed. 59(23). 5887–91. 89 indexed citations
15.
Suganuma, Masashi. (1998). Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis. 19(10). 1771–1776. 444 indexed citations
16.
Suganuma, Masashi, Yoichi Sakurai, Masahiro Ochiai, et al.. (1997). Cardiac metastasis from squamous cell carcinoma of gallbladder. Journal of Gastroenterology. 32(6). 852–856. 21 indexed citations
17.
Suganuma, Masashi, et al.. (1995). A Case of AFP-Producing Early Gastric Cancer with Metastasizing to the Liver.. The Japanese Journal of Gastroenterological Surgery. 28(5). 1086–1089. 3 indexed citations
18.
Imazu, Hiroki, Masahiro Ochiai, Takahiko Funabiki, et al.. (1995). A CASE OF MUSCULAR HAMARTOMA OF THE BREAST. The journal of the Japanese Practical Surgeon Society. 56(10). 2058–2061. 1 indexed citations
19.
Suganuma, Masashi, Masahiro Ochiai, Hiroki Imazu, et al.. (1994). A CASE OF LEIOMYOSARCOMA OF THE STOMACH IN WHICH REPERATED METASTASIS WAS SUCCESSFULLY EXCISED SEVEN TIMES AND PROLIFERATION ACTIVITY COULD BE PURSURED. The journal of the Japanese Practical Surgeon Society. 55(9). 2331–2336.
20.
Ochiai, Masahiro, Hiroki Imazu, Takahiko Funabiki, et al.. (1992). Case Report of Early Gastric Carcinoma after Surgery for Metastatic Ovarian Tumors.. The Japanese Journal of Gastroenterological Surgery. 25(11). 2794–2798.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026